Barbora Weinbergerova

24PUBLICATIONS
287CO-AUTHORS
Medical virologyMedical mycologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Jon Salmanton-García, Francesco Marchesi, Erica Mackenzie

|Oct 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner

|Aug 21, 2025
Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation.

Veronika Zimolova, Monika Burocziova, Linda Berkova

|Jul 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch

|Jan 28, 2025
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.

Jiří Mayer, Petra Čičátková, Lenka Kováčová

|Sep 16, 2024
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia.

Christoph Röllig, Björn Steffen, Christoph Schliemann

Pageof 4

Frequent Collaborators

11 joint publications

Livio Pagano

11 joint publications

Jon Salmanton-García

11 joint publications

Francesco Marchesi

11 joint publications

Oliver A Cornely